Status:
COMPLETED
EMBRACE1: Prostate Biorepository
Lead Sponsor:
Caris Science, Inc.
Conditions:
Prostate Cancer
Eligibility:
MALE
18+ years
Brief Summary
The objective of this multi-center prospective observational clinical study is to evaluate the clinical performance of the Carisome Prostate assay as an aid in the diagnosis of prostate cancer in men ...
Eligibility Criteria
Inclusion
- Men scheduled for a routine prostate biopsy expected to produce a pathology evaluation and report
- Blood draw within 7 days prior to scheduled prostate biopsy procedure
- Blood draw on the day of but prior to biopsy
Exclusion
- Any previous diagnosis of cancer with the exception of non-melanoma skin cancer
- Any prior or ongoing treatment for prostate cancer including prostatectomy or hormone therapy
- Prostate biopsy within one month of blood draw
- Previous enrollment in the Caris Life Sciences Biorepository
Key Trial Info
Start Date :
December 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2012
Estimated Enrollment :
1290 Patients enrolled
Trial Details
Trial ID
NCT01499381
Start Date
December 1 2011
End Date
July 1 2012
Last Update
June 9 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Caris Science, Inc.
Phoenix, Arizona, United States